Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. - Wikidata - awgldk - TriplyDB

Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases.

Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases.

http://www.wikidata.org/entity/Q34012029

about

Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR Erythropoietin and diabetes mellitus FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy New Insights for Oxidative Stress and Diabetes Mellitus Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy Alpha-Lipoic Acid and Antioxidant Diet Help to Improve Endothelial Dysfunction in Adolescents with Type 1 Diabetes: A Pilot Trial.Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical Application Regeneration in the nervous system with erythropoietin Role of alpha-lipoic acid in ameliorating Cyclosporine A-induced pancreatic injury in albino rats: A structural, ultrastructural, and morphometric study.Measuring In Vivo Free Radical Production by the Outer Retina.Inhibitory Effects of α-Lipoic Acid on Oxidative Stress-Induced Adipogenesis in Orbital Fibroblasts From Patients With Graves Ophthalmopathy.Efficacy of α-lipoic acid in diabetic neuropathy.Programming apoptosis and autophagy with novel approaches for diabetes mellitus.Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases.Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential.Chronic treatment of (R)-α-lipoic acid reduces blood glucose and lipid levels in high-fat diet and low-dose streptozotocin-induced metabolic syndrome and type 2 diabetes in Sprague-Dawley rats.Bioprotective carnitinoids: lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury: mitochondrial drugs come of age.mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.A Caenorhabditis elegans Model Elucidates a Conserved Role for TRPA1-Nrf Signaling in Reactive α-Dicarbonyl Detoxification.Protective effects of alpha lipoic acid on high glucose-induced neurotoxicity in PC12 cells.Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.Effects of Alpha Lipoic Acid on Multiple Cytokines and Biomarkers and Recurrence of Atrial Fibrillation Within 1 Year of Catheter Ablation.Gadolinium induced effects on mammalian cell motility, adherence and chromatin structure.Beneficial Effect of Bis(Hinokitiolato)Zn Complex on High-fat Diet-induced Lipid Accumulation in Mouse Liver and Kidney.Efficacy of Nutritional Interventions on Inflammatory Markers in Haemodialysis Patients: A Systematic Review and Limited Meta-Analysis.Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.Mitochondrial Agents for Bipolar Disorder.Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients.The potential protective effect of α-lipoic acid against nanocopper particle-induced hepatotoxicity in male rats.Lipoic Acid and Progesterone Alone or in Combination Ameliorate Retinal Degeneration in an Experimental Model of Hereditary Retinal Degeneration.Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats

P2860

Q26382049-BD1A3BF3-215B-4E4F-948C-7208E03352FC Q26749047-B1D94062-7EE7-4905-9411-A48E05CDA9DD Q26777878-542BCE44-BECB-40CA-97F2-C461FBEFD477 Q26800615-C2DC39EF-7251-4F9C-AA60-EEAC73268E9A Q26822734-EAD96505-7F8A-4AE2-9F7A-199F7B5BAC1C Q28066377-2ADE15A9-B202-4EE5-91D6-50CE4116F081 Q28080679-2B5FDA75-3E86-45C3-B97D-C03CE9B34987 Q28085715-415266F0-4EB3-40E9-B4F6-F92669F72342 Q29248994-8FE7ADB0-94ED-4AEB-BFFE-006F8E68524C Q35773388-B218BFB0-5B52-419E-B2E9-5FEF7D9AD28B Q35806779-B52EE2B9-AF14-4594-925A-FE51B35C750E Q36247651-1E1F5305-6A1C-4D94-82CD-F012C04D4082 Q36300586-6D1023EA-6FCA-4086-B05E-9CC98EE89191 Q36380581-F069F2C9-70E9-4F30-834C-5891FFF3CB2B Q36478242-7B64F8DD-B62B-48F5-88C9-23FC7B2BFFD6 Q38266297-86C5C155-1567-489E-8F1E-DC485E312E9C Q38367977-CFFB38DD-0D8D-4D67-B3A6-B692A3A4B230 Q38742951-6CEF78FC-FA2B-4505-84B1-FD161838560A Q39414338-779A77C6-83D2-4FE7-ACE3-5D12396A2217 Q41853406-7352F6AC-99D0-46C7-9E53-81E1982B63AB Q41953858-9FAD89A5-ACE7-4A89-BACA-ABE56F5FEAFA Q42031136-90EC9FF9-2CB8-4E0C-830B-B514A88CCE38 Q44475765-6435FEFC-DEC6-4301-83DF-0510F146BA8C Q46813352-0EECFD34-2230-4F31-92BA-4527BCC5C9AD Q47988632-BBBE0DFF-1A71-4FD0-97A0-05E66844E777 Q48281853-50950AA1-C3FE-4A23-8978-5B0F516FB4BC Q48283469-6080041E-7D77-496B-8AAE-17F6F43D446C Q49267983-4055565E-D103-43DE-BBB2-C291BB4D8458 Q51736055-2CBB68B3-100B-491C-8FFE-0B61ADC4604C Q51761339-0AA5242E-E03B-4938-A0AC-AA611FC3F1B2 Q52621890-BABE5C2F-A203-489B-AD8A-39626AD45361 Q52843844-A6AE1504-4F4A-4B78-9EE0-5B93554986D3 Q53746490-55215810-AA40-41E2-8AA1-A5CDF87C9CC0 Q54940443-B4E31DC8-99B1-46A1-B1D6-659656A74889 Q57065540-C4958248-2344-4254-97AC-285ECCB4ECD3

P2860

Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases.

http://www.wikidata.org/entity/Q34012029

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Alpha-lipoic acid as a pleiotr ...... es and other chronic diseases.

@ast

Alpha-lipoic acid as a pleiotr ...... es and other chronic diseases.

@en

Alpha-lipoic acid as a pleiotr ...... es and other chronic diseases.

@nl

type

label

Alpha-lipoic acid as a pleiotr ...... es and other chronic diseases.

@ast

Alpha-lipoic acid as a pleiotr ...... es and other chronic diseases.

@en

Alpha-lipoic acid as a pleiotr ...... es and other chronic diseases.

@nl

prefLabel

Alpha-lipoic acid as a pleiotr ...... es and other chronic diseases.

@ast

Alpha-lipoic acid as a pleiotr ...... es and other chronic diseases.

@en

Alpha-lipoic acid as a pleiotr ...... es and other chronic diseases.

@nl

P1433

Q34012029-E5B5366D-B9D2-48E6-914A-A5E2A10CA2DE

P1476

Q34012029-49053144-C00D-48CE-858E-07FBB1C335AE

P2093

Q34012029-5B9930BA-CE6E-4A2C-B8FE-EC0998386C21

Q34012029-B8E53A44-27D5-46BD-BB24-605CA8FAD9E0

P2860

Q34012029-0080ADBC-6D96-446E-95F4-1F89FBB1FA2D

Q34012029-01D27B88-B533-43D7-BD34-FD35CE311FDC

Q34012029-027007FD-0F84-4176-BB07-CC707E8DD749

Q34012029-033B0F3C-3D88-4595-9ED8-1EABB8F5BA07

Q34012029-092EA1CB-B469-45B9-BC27-E03D3057A22F

Q34012029-094F2101-7A9D-461D-9DEC-81D677C126C9

Q34012029-09810DAF-D03A-4F10-93A9-A8B53A2DD4F6

Q34012029-0C574126-7879-46F1-849E-F1E846227EBC

Q34012029-0F73405C-D133-4A34-84E3-D87E6AB82152

Q34012029-0FBE9B20-5A79-4AC7-A176-AE63B1A97094

P2888

Q34012029-C79BA643-B490-47F1-8990-A9085FD02C02

P304

Q34012029-CFAA6AF4-66AD-4F53-B50B-2FABBA6C5635

P31

Q34012029-6ECAFE09-638E-436A-A839-C66E721F68C6

P356

Q34012029-0CE63128-C206-4DEF-B45E-405E6E732F31

P433

Q34012029-FCBDBDD8-72FF-4948-875A-11A907BE51EE

P478

Q34012029-2C45045D-D954-4FC8-AE29-088D2AA24B7E

P577

Q34012029-02EC0BE3-D309-4AE6-918F-1338304075CF

P5875

Q34012029-A2F5DE11-C032-49EB-B078-A9E4CB87C717

P6179

Q34012029-8C19E800-4601-4DEC-8851-8CB36AC386FA

P698

Q34012029-57EA7477-73CF-4641-AEA1-D0DB7A444AC8

P932

Q34012029-2B999B3A-F391-428F-8D5E-66D19A7BAA0A

P356

P1433

Diabetology and Metabolic Syndrome

P1476

Alpha-lipoic acid as a pleiotr ...... es and other chronic diseases.

@en

P2093

Carlos Antonio Negrato

http://www.w3.org/2001/XMLSchema#string

Marilia Brito Gomes

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha lipoic Acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials

Role of AMP-activated protein kinase in mechanism of metformin action

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes

Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.

Burning mouth syndrome

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

Sodium dependent multivitamin transporter (SMVT): a potential target for drug delivery

P2888

P304

80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1758-5996-6-80

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264629816

http://www.w3.org/2001/XMLSchema#string

P6179

1002309246

http://www.w3.org/2001/XMLSchema#string

P698

25104975

http://www.w3.org/2001/XMLSchema#string

P932

4124142

http://www.w3.org/2001/XMLSchema#string